This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-follicular lymphoma
CD2_NONFOLLICULAR_LYMPHOMA
neoplasm of mature B-cells: A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3604 |
4. Check minimum number of eventsNone |
3604 |
5. Include endpointsNone |
3604 |
6. Filter based on genotype QC (FinnGen only) |
3604 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphoma non-Hodgkin diffusum
Similar endpoints
↥List of similar endpoints to
Non-follicular lymphoma
based on the number of shared cases.
Similar with more cases:
- Non-follicular lymphoma, hilmo, excluding all cancers
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3604 | 1498 | 2106 |
| Unadjusted period prevalence (%) | 0.75 | 0.51 | 0.93 |
| Median age at first event (years) | 66.07 | 64.47 | 67.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3254
- Matched controls
- 32539
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN6AD
NOMESCO Finland
CT of torso and neck
40.7
323.0
414
116
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.6
323.0
767
1014
A03FA01
ATC
metoclopramide; systemic, rectal
7.9
323.0
1710
4005
M04AA01
ATC
allopurinol; systemic
8.7
323.0
1520
2972
L03AA02
ATC
filgrastim; parenteral
48.8
323.0
993
290
L03AA13
ATC
pegfilgrastim; parenteral
29.6
323.0
895
412
A04AA01
ATC
ondansetron; systemic, rectal
10.0
323.0
763
967
WW500
NOMESCO Finland
Blood transfusion
16.3
323.0
728
565
JN4BD
NOMESCO Finland
Extensive body CT
9.9
323.0
1349
2170
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
62.6
323.0
873
189
XW000
NOMESCO Finland
Bone marrow biopsy
27.5
323.0
1100
592
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
323.0
309
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16384.0
323.0
1820
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
139.8
323.0
488
41
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
323.0
400
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
323.0
365
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
4069.3
323.0
373
*
1XC02
NOMESCO Finland
NA
133.5
323.0
357
30
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
26.2
323.0
1036
569
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
47.2
323.0
443
108
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
333
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
454
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
25.6
323.0
595
282
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
176.7
323.0
2383
495
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
69.9
323.0
678
122
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
64.7
308.1
358
62
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
307.2
290
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
33.3
298.8
397
135
D70.82
ICD-10 Finland
Drug-induced neutropenia
28.8
290.4
401
158
JN4AD
NOMESCO Finland
Body CT examination
7.0
282.5
781
1404
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
31.3
271.3
366
131
PJA10
NOMESCO Finland
Exploration of lymph nodes
38.1
270.5
348
102
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
168.7
266.5
278
18
H02AB06
ATC
prednisolone; systemic
3.7
263.5
2156
11305
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
11.3
261.3
522
543
ZX120
NOMESCO Finland
Intravenous
5.9
244.6
779
1655
A04AA02
ATC
granisetron; systemic, transdermal
8.0
242.4
596
885
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
237.1
875
2196
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
228.9
217
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
39.7
227.7
290
80
L03AA14
ATC
lipegfilgrastim; parenteral
20.7
213.7
326
174
R50.9
ICD-10 Finland
Fever, unspecified
4.5
213.0
899
2556
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
17.8
185.9
299
184
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
174.7
1447
6847
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.6
165.2
462
800
C82.1
ICD-10 Finland
Follicular lymphoma grade II
39.6
163.4
208
56
WW300
NOMESCO Finland
Transfer of autologic stem cells
72.0
160.8
184
27
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
18.5
152.5
241
140
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
27.9
145.7
202
77
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
86.8
140.6
157
19
N02AA05
ATC
oxycodone; systemic
3.3
140.4
851
3137
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
18.0
139.1
222
132
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
138.7
752
2543
H02AB07
ATC
prednisone; oral
3.4
137.2
801
2863
J05AB11
ATC
valaciclovir; oral
3.7
137.0
688
2183
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
130.2
1828
11118
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
25.6
129.7
184
76
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
127.9
122
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
44.8
124.3
154
36
A02BC02
ATC
pantoprazole; systemic
2.5
123.1
2359
16654
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.6
122.3
235
216
H02AB02
ATC
dexamethasone; systemic
3.8
121.3
592
1816
ZX112
NOMESCO Finland
Subcutaneous
9.7
119.7
253
279
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.5
115.7
223
206
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
16.1
111.6
185
121
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
107.9
103
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
21.4
106.2
159
78
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
105.2
383
885
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.8
104.0
276
435
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
14.3
102.8
179
132
XX9CD
NOMESCO Finland
Very extensive complementary CT
266.1
101.3
103
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
98.1
399
1027
J01MA12
ATC
levofloxacin; systemic
2.6
98.0
896
4160
212
Kela drug reimbursment
Gout
7.5
97.2
242
347
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.9
96.2
253
393
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
60.4
94.6
111
19
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
91.8
248
399
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
49.9
91.6
111
23
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.7
90.4
155
110
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
88.9
85
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
85.8
82
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.5
84.1
266
522
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
62.4
83.2
97
16
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
33.1
82.6
109
34
B72
ICPC
Hodgkin Lymphoma
102.8
82.3
90
9
L01AA02
ATC
chlorambucil; oral
48.5
81.4
99
21
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
52.0
79.9
96
19
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
75.6
510
1933
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
75.3
72
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.5
75.1
235
454
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
74.2
71
*
WF002
NOMESCO Finland
Radical radiotherapy
3.8
73.6
335
945
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
73.2
70
*
WW409
NOMESCO Finland
Other aferesis
48.1
73.1
89
19
Z51.5
ICD-10 Finland
Palliative care
3.6
72.8
356
1066
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
71.8
363
1116
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
69.9
71.6
82
12
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
245.3
70.6
72
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.4
69.1
219
429
ZX108
NOMESCO Finland
Inhalation
20.0
69.1
105
54
TAB00
NOMESCO Finland
Lumbar puncture
4.8
68.2
243
542
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.0
68.1
292
779
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
67.9
65
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
67.9
65
*
TGC00
NOMESCO Finland
Bronchial lavation
5.6
67.6
206
385
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
67.3
248
572
L01CB01
ATC
etoposide; systemic
21.0
66.9
100
49
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.6
66.0
139
151
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
65.8
63
*
WZC30
NOMESCO Finland
Teaching
2.5
65.6
573
2518
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
33.5
64.8
85
26
WF004
NOMESCO Finland
Palliative radiotherapy
6.8
63.0
165
253
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
28.4
62.9
86
31
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
62.7
60
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.3
62.7
250
623
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
61.6
59
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
61.6
59
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
163.1
61.1
64
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
60.9
987
5766
J05AB01
ATC
aciclovir; systemic
2.2
59.8
736
3820
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
59.8
504
2164
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.7
59.7
113
100
YNB10
NOMESCO Finland
Collection of stem cells for transplant
94.7
59.0
65
7
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
108.8
59.0
64
6
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.1
58.6
109
93
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
58.1
874
4940
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
93.3
58.0
64
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
57.9
806
4407
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
13.7
57.5
101
76
A07AA02
ATC
nystatin; oral
3.2
56.2
322
1080
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
56.2
981
5864
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.4
53
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
55.0
297
954
B01AB05
ATC
enoxaparin; parenteral
1.9
54.0
1129
7182
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
53.6
387
1510
D69.5
ICD-10 Finland
Secondary thrombocytopenia
27.0
53.5
74
28
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
52.3
285
921
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
27.2
52.2
72
27
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
52.2
50
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
52.2
50
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
51.2
49
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
51.7
51.0
61
12
JN4CD
NOMESCO Finland
Very extensive body CT
3.7
50.2
230
647
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
44.3
49.6
61
14
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.3
49.2
122
173
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
49.1
47
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
49.1
47
*
1AA09
NOMESCO Finland
NA
172.6
49.0
51
*
WW402
NOMESCO Finland
Leucoferesis
53.6
48.8
58
11
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
47.9
453
2051
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
47.7
428
1886
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
47.0
45
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.5
46.3
170
390
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
45.4
634
3424
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
49.9
44.9
54
11
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.9
43
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
31.6
44.6
59
19
B01AB10
ATC
tinzaparin; parenteral
2.8
43.8
309
1183
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
11.5
43.4
82
73
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
433.2
43.3
43
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
42.2
1027
6740
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
55.2
41.5
49
9
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
40.7
39
*
390
Kela drug reimbursment
Ibrutinib
45.2
40.1
49
11
TPX15
NOMESCO Finland
Removal of vascular injection port
16.7
39.9
64
39
WW200
NOMESCO Finland
Immunization
4.3
39.6
152
364
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
52.9
39.6
47
9
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.8
39.5
102
154
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
38.8
418
2005
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.7
38.7
137
303
JMA10
NOMESCO Finland
Transabdominal total splenectomy
14.3
38.7
66
47
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.6
37
*
H02AB09
ATC
hydrocortisone; systemic
5.0
38.5
129
269
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.6
38.2
69
56
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
37.9
673
3951
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.2
37.4
85
106
J01MA14
ATC
moxifloxacin; systemic
2.4
37.4
352
1577
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
70.7
37.0
42
6
ZXE00
NOMESCO Finland
One hour or less
1.6
36.9
1246
8905
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
36.5
35
*
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
60.7
36.2
42
7
ZX131
NOMESCO Finland
Intrathecal
187.0
35.8
37
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
12.0
35.8
66
56
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
15.4
35.7
59
39
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.3
35.6
138
334
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
34.9
310
1349
WX110
NOMESCO Finland
Local anesthesy
1.6
34.6
1997
16268
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
34.4
33
*
FM1FN
NOMESCO Finland
Heart function isotope examination
13.3
34.1
60
46
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
33.4
32
*
N02BE01
ATC
paracetamol; systemic, rectal
1.7
33.1
2689
23816
EMA10
NOMESCO Finland
Biopsy of tonsil
22.1
33.1
48
22
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
32.7
1471
11201
C03CA01
ATC
furosemide; systemic
1.6
32.5
1080
7614
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
15.8
32.5
53
34
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
32.3
31
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.3
31
*
1512
Kela drug reimbursment
Ibrutinib
40.5
32.1
40
10
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
31.7
202
721
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
27.2
31.5
43
16
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
31.3
402
2070
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
31.1
139
383
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
28.3
31.1
42
15
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
161.5
30.7
32
*
L01XE27
ATC
[U] ibrutinib; oral
46.7
30.6
37
8
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.2
30.6
75
106
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
31.1
30.3
40
13
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
30.2
29
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
28.9
308
1460
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
11.4
28.3
53
47
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
28.2
27
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
11.2
28.0
53
48
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
64.6
27.9
32
5
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
33.1
27.8
36
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
27.6
1163
8613
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.6
27.5
60
71
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.3
27.1
104
250
L01BB05
ATC
fludarabine; systemic
22.6
26.5
38
17
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
20.8
26.5
39
19
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
11.3
26.1
49
44
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
8.3
26.0
58
71
R06AE07
ATC
cetirizine; oral
1.5
26.0
1192
8966
B02.9
ICD-10 Finland
Zoster without complication
2.4
25.9
227
975
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
40.4
25.8
32
8
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
136.1
25.6
27
*
1CX01
NOMESCO Finland
NA
33.3
25.5
33
10
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.3
25.5
131
405
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
25.0
24
*
J02AC01
ATC
fluconazole; systemic
1.5
25.0
969
6995
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
24.8
85
183
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
252.0
24.7
25
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
7.2
24.6
60
85
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
24.0
23
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
37.8
23.9
30
8
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
12.1
23.7
43
36
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
23.6
142
490
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
125.9
23.6
25
*
JFB00
NOMESCO Finland
Partial resection of small intestine
4.3
23.5
89
212
3AA13
NOMESCO Finland
NA
19.6
23.4
35
18
A79
ICPC
Malignancy NOS
5.0
23.2
76
156
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
28.4
23.1
31
11
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
22.9
22
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
22.9
22
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
15.6
22.8
37
24
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
22.7
1113
8425
Z52.89
ICD-10 Finland
Donor of other organ or tissue
40.4
22.7
28
7
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
120.8
22.6
24
*
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
120.8
22.6
24
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
23.1
22.6
32
14
KFC00
NOMESCO Finland
Unilateral orchiectomy
8.6
22.5
49
58
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
22.5
347
1911
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.6
22.4
102
287
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
22.2
969
7140
J01DB01
ATC
cefalexin; oral
1.5
22.1
2446
21752
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
21.9
21
*
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
21.9
21
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
21.9
1014
7569
4701
FHL
Neck lymph node removal
18.5
21.7
33
18
JAH00
NOMESCO Finland
Laparotomy
3.3
21.7
111
343
KA1FN
NOMESCO Finland
Isotope renography
7.0
21.4
53
77
N05CF01
ATC
zopiclone; oral
1.5
21.4
1022
7669
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.5
21.1
76
173
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
20.9
1156
8935
Z2221
NOMESCO Finland
Medical doctor
1.5
20.8
804
5749
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
20.8
130
461
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
20.6
307
1664
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
110.7
20.6
22
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.9
20.5
84
217
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
11.3
20.4
38
34
ZXD05
NOMESCO Finland
Urgent procedure
1.5
20.3
913
6746
Z2446
NOMESCO Finland
Social worker
2.2
20.0
207
968
CAA30
NOMESCO Finland
Biopsy of orbit
57.9
19.9
23
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
19.8
741
5252
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
19.8
19
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
19.8
19
*
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
73.9
19.7
22
*
127
Kela drug reimbursment
Transplant complication
4.4
19.6
72
168
A41.8
ICD-10 Finland
Other specified sepsis
3.7
19.6
85
231
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.2
19.5
103
326
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.2
19.5
74
178
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
8.5
19.4
42
50
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
15.6
19.2
31
20
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
5.1
19.2
61
122
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.5
19.0
67
150
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.6
19.0
66
146
L01EL01
ATC
ibrutinib; oral
34.5
18.9
24
7
GEA00
NOMESCO Finland
Mediastinoscopy
9.6
18.8
38
40
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.8
18
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.8
18
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
70.3
18.7
21
*
9101
FHL
Bone biopsy
28.0
18.7
25
9
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
17.2
18.7
29
17
N02AX02
ATC
tramadol; systemic, rectal
1.4
18.6
1301
10443
372
Kela drug reimbursment
Idelalisib
100.6
18.6
20
*
1BC01
NOMESCO Finland
NA
100.6
18.6
20
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
191.0
18.5
19
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.5
18.4
54
99
V03AF03
ATC
calcium folinate; systemic
13.6
18.2
31
23
WX002
NOMESCO Finland
Sedation and analgesia
1.6
18.2
615
4246
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
18.1
116
419
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
52.8
17.9
21
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
17.7
17
*
E83.50
ICD-10 Finland
Hypercalcemia
4.4
17.6
64
148
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
180.9
17.5
18
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.6
17.4
78
218
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.5
17.4
83
244
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
17.4
196
952
J02AC03
ATC
voriconazole; systemic
17.0
17.4
27
16
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
18.7
17.3
26
14
120
Kela drug reimbursment
Hypogammaglobulinaemia
18.7
17.3
26
14
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
17.2
298
1706
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
17.2
136
557
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
31.6
17.0
22
7
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
14.1
16.8
28
20
JAH21
NOMESCO Finland
Staging laparoscopy
63.6
16.7
19
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
16.7
16
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
16.7
16
*
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.7
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.7
16
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
6.1
16.6
45
75
N03AX16
ATC
pregabalin; oral
1.5
16.6
677
4866
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
16.6
106
383
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
16.4
16.5
26
16
J01CA04
ATC
amoxicillin; systemic
1.4
16.4
2276
20356
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.2
16.3
50
97
Z3231
NOMESCO Finland
Registered nurse
1.4
16.2
821
6164
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
12.8
16.1
28
22
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
18.6
16.0
24
13
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
5.5
15.8
46
84
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
15.8
147
653
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
15.6
15
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
17.3
15.6
24
14
C82
ICD-10 Finland
Follicular lymphoma
160.7
15.5
16
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
160.7
15.5
16
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
160.7
15.5
16
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
160.7
15.5
16
*
R4110
NOMESCO Finland
Physiotherapy
1.4
15.5
766
5718
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.5
15.4
71
204
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
38.2
15.4
19
5
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.5
15.3
71
205
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
28.7
15.2
20
7
ZXA00
NOMESCO Finland
Right side
1.4
15.1
835
6359
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
23.5
15.1
21
9
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
20.1
15.1
22
11
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
15.1
192
982
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
14.9
248
1398
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
14.9
113
453
A02BA02
ATC
ranitidine; systemic
1.5
14.8
607
4356
B02
ICPC
Lymph gland(s) enlarged/painful
6.7
14.8
37
56
JAH01
NOMESCO Finland
Laparoscopy
2.5
14.6
114
464
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.6
14
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
14.6
14
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.6
14.6
37
57
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
11.9
14.5
26
22
L01XX47
ATC
[U] idelalisib; oral
150.6
14.5
15
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
150.6
14.5
15
*
ZX080
NOMESCO Finland
Image guided radiotherapy
3.1
14.4
78
254
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
14.3
485
3334
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.5
14.3
50
113
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
19.2
14.2
21
11
D73.1
ICD-10 Finland
Hypersplenism
22.3
14.2
20
9
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
10.5
14.2
27
26
CFA20
NOMESCO Finland
Biopsy of conjunctiva
13.4
14.2
24
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
14.1
545
3854
WX402
NOMESCO Finland
General anaesthesia
1.6
14.1
431
2892
B74
ICPC
Malignant neoplasm blood other
14.5
14.0
23
16
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
14.5
14.0
23
16
B03XA02
ATC
darbepoetin alfa; parenteral
3.2
14.0
74
237
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
10.1
13.9
27
27
A02BC01
ATC
omeprazole; systemic
1.4
13.9
835
6439
A05AA02
ATC
ursodeoxycholic acid; oral
4.1
13.9
53
130
TGD00
NOMESCO Finland
Needle biopsy of lung
5.9
13.9
38
65
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
12.7
13.9
24
19
UJF32
NOMESCO Finland
Coloscopy
1.4
13.8
798
6115
TK800
NOMESCO Finland
Hemodialysis
2.9
13.7
82
286
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
13.7
521
3673
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.2
13.6
41
79
C82.0
ICD-10 Finland
Follicular lymphoma grade I
75.4
13.6
15
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
75.4
13.6
15
*
R4190
NOMESCO Finland
Nutritional therapy
2.6
13.6
97
377
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
13.5
13
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
13.5
128
577
R50.8
ICD-10 Finland
Other specified fever
7.2
13.5
32
45
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
10.9
13.5
25
23
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
10.9
13.5
25
23
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
13.4
938
7415
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.1
13.4
51
125
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
13.4
194
1043
A06AD11
ATC
lactulose; oral
1.5
13.4
466
3223
Z51.0
ICD-10 Finland
Radiotherapy session
3.8
13.4
55
145
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
25.8
13.4
18
7
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.9
13.3
82
291
EMB10
NOMESCO Finland
Tonsillectomy
2.5
13.3
105
431
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
40.2
13.1
16
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
13.0
124
560
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.0
12.9
161
816
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
12.8
183
979
B01AB04
ATC
dalteparin; parenteral
2.0
12.8
164
843
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.1
12.7
48
117
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.0
12.7
34
57
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
12.3
12.6
22
18
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
12.3
12.6
22
18
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.7
12.6
54
148
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.5
12.5
43
96
1DB01
NOMESCO Finland
NA
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
12.5
12
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
12.5
12
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
12.5
12
*
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
12.5
12
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
12.5
12
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
17.4
12.5
19
11
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
130.5
12.4
13
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
6.9
12.4
30
44
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
12.3
936
7483
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.1
12.2
47
117
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.7
12.2
52
142
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.2
12.2
45
108
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
12.2
478
3388
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
12.1
599
4443
WX892
NOMESCO Finland
Monitored bed care
1.7
12.1
231
1362
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
8.7
12.0
25
29
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
12.0
156
807
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.3
11.9
35
66
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.9
11.9
48
125
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
11.9
252
1531
WX882
NOMESCO Finland
High dependency care
2.4
11.9
100
426
ELB30
NOMESCO Finland
Excision of submandibular gland
6.8
11.9
29
43
D73.9
ICD-10 Finland
Disease of spleen, unspecified
46.8
11.9
14
*
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
10.5
11.7
22
21
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
6.6
11.7
29
44
J35.1
ICD-10 Finland
Hypertrophy of tonsils
5.0
11.7
36
72
J01MA02
ATC
ciprofloxacin; systemic
1.3
11.6
1151
9554
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
7.7
11.6
26
34
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.6
11.6
85
337
WX199
NOMESCO Finland
Other local analgesia
2.5
11.6
91
374
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
11.5
150
774
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.4
11.5
98
421
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
11.5
277
1747
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.5
11
*
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
+∞
11.5
11
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.7
11.4
76
285
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
11.3
643
4891
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.4
11.3
95
404
WX720
NOMESCO Finland
Own respiration
2.2
11.2
114
531
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
11.2
116
544
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.4
11.2
39
89
ZX114
NOMESCO Finland
Intramuscular
3.4
11.1
53
159
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
25.1
11.1
15
6
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
12.7
11.1
19
15
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.7
11.1
77
294
L01AA01
ATC
cyclophosphamide; systemic
6.1
11.0
29
48
L04AD01
ATC
ciclosporin; systemic
2.9
11.0
64
221
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
43.4
10.9
13
*
B02
ICD-10 Finland
Zoster [herpes zoster]
2.2
10.9
104
471
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
10.9
163
888
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
5.5
10.8
31
57
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
17.9
10.7
16
9
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
60.2
10.6
12
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
60.2
10.6
12
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
10.4
167
931
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
10.4
10
*
3AX16
NOMESCO Finland
NA
+∞
10.4
10
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
10.4
10
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
10.4
255
1620
399
Kela drug reimbursment
Venetoclax
32.6
10.3
13
*
ZXA05
NOMESCO Finland
Left side
1.3
10.3
755
5972
Z31.6
ICD-10 Finland
General counselling and advice on procreation
8.2
10.3
22
27
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.0
10.3
56
186
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
5.1
10.3
31
61
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
18.8
10.2
15
8
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.2
10.2
37
88
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
23.4
10.2
14
6
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.4
10.1
86
370
R05
ICD-10 Finland
Cough
1.4
10.1
512
3803
J94.8
ICD-10 Finland
Other specified pleural conditions
2.8
10.1
63
226
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.6
10.1
72
282
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
10.1
65
241
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
10.0
117
579
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
5.9
9.8
26
44
B73
ICPC
Leukaemia
10.6
9.8
18
17
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
9.7
168
960
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
13.4
9.7
16
12
D73.0
ICD-10 Finland
Hyposplenism
55.1
9.6
11
*
ENA10
NOMESCO Finland
Biopsy of pharynx
6.8
9.6
23
34
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.4
9.6
78
327
JN4DD
NOMESCO Finland
Scout CT scan of torso
11.4
9.5
17
15
C10AA07
ATC
rosuvastatin; oral
0.7
9.5
425
5621
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
7.1
9.5
22
31
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
9.5
134
716
C90.0
ICD-10 Finland
Multiple myeloma
3.3
9.4
46
142
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
100.3
9.4
10
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.3
9.4
33
77
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
9.4
9
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
9.4
9
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
L04AA01
ATC
[U] ciclosporin; systemic
3.1
9.3
50
165
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
12.4
9.3
16
13
Z51.88
ICD-10 Finland
Other specified medical care
2.6
9.3
64
246
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
21.7
9.3
13
6
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
9.3
305
2078
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
10.7
9.3
17
16
HA1AA
NOMESCO Finland
X-ray mammography
1.7
9.3
175
1032
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
9.2
176
1038
L04AA06
ATC
mycophenolic acid; systemic
2.9
9.2
53
182
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
7.3
9.2
21
29
WF099
NOMESCO Finland
Other radiotherapy
4.8
9.1
29
61
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
4.3
9.1
32
75
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.7
9.0
58
215
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.3
9.0
83
370
L01XX52
ATC
venetoclax; oral
36.8
9.0
11
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
36.8
9.0
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.6
9.0
39
110
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.2
9.0
32
76
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
18.6
8.9
13
7
JAH20
NOMESCO Finland
Staging laparotomy
24.1
8.9
12
5
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
6.1
8.9
23
38
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.3
8.9
31
72
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
12.5
8.9
15
12
GD6AD
NOMESCO Finland
CT of chest and neck
8.0
8.8
19
24
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
3.7
8.8
37
102
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.3
8.8
22
35
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
8.7
128
695
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
14.0
8.7
14
10
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
50.1
8.7
10
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.7
8.6
56
210
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
8.6
189
1167
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
8.6
195
1211
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
4.2
8.6
31
75
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.5
8.5
66
272
P01BA02
ATC
hydroxychloroquine; oral
1.6
8.5
209
1325
A06AH03
ATC
naloxegol; oral
3.3
8.5
40
121
B59
ICD-10 Finland
Pneumocystosis
27.6
8.5
11
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
27.6
8.5
11
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.0
8.5
47
160
SPAT1153
SPAT
Removal of sutures
1.3
8.5
927
7727
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
20.1
8.5
12
6
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
5.1
8.4
25
49
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.6
8.4
197
1234
1CA02
NOMESCO Finland
NA
90.3
8.4
9
*
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
90.3
8.4
9
*
9689/3-C42.1
ICD-O-3
Splenic marginal zone B-cell lymphoma of bone marrow
90.3
8.4
9
*
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
90.3
8.4
9
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
90.3
8.4
9
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
90.3
8.4
9
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
12.8
8.4
14
11
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.1
8.3
31
77
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
8.3
8
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
8.3
8
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
8.3
8
*
3AF07
NOMESCO Finland
NA
+∞
8.3
8
*
9670/3-C42.1
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of bone marrow
+∞
8.3
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.3
8
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
8.3
8
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.2
195
1225
CBA10
NOMESCO Finland
Biopsy of eyelid
3.5
8.2
36
103
A03
ICPC
Fever
1.5
8.2
317
2233
A02BC05
ATC
esomeprazole; systemic
1.3
8.2
1076
9165
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
8.2
175
1071
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
8.2
199
1260
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.1
8.1
30
74
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.6
8.1
56
216
B04
ICPC
Blood symptom/complaint
5.4
8.1
23
43
A07AA09
ATC
vancomycin; oral
2.8
8.1
48
170
D11.70
ICD-10 Finland
Gland sublingual
8.1
8.1
17
21
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
17.2
8.1
12
7
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
8.1
79
364
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
6.8
8.1
19
28
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
5.0
8.0
24
48
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.8
8.0
48
172
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
8.0
170
1039
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.1
8.0
89
438
G53.0
ICD-10 Finland
Postzoster neuralgia
3.9
7.9
31
81
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.7
7.9
32
86
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
7.0
7.8
18
26
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
7.8
384
2836
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
7.4
7.7
17
23
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.0
7.6
91
460
I50.1
ICD-10 Finland
Left ventricular failure
1.7
7.6
151
903
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.5
7.6
54
215
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
11.9
7.6
13
11
J01FF01
ATC
clindamycin; systemic
1.3
7.6
719
5872
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.8
7.5
122
687
CKA10
NOMESCO Finland
Biopsy of vitreous body
8.9
7.5
15
17
A04AD12
ATC
aprepitant; systemic
2.5
7.5
54
216
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.7
7.5
48
177
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
5.4
7.5
21
39
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.5
940
7945
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.3
7.5
66
293
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
4.8
7.4
23
48
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
80.3
7.4
8
*
L57.0
ICD-10 Finland
Actinic keratosis
1.4
7.4
301
2146
S18
ICPC
Laceration/cut
1.2
7.3
1177
10227
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
7.3
150
907
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
7.3
7
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
V03AB28
ATC
NA
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
+∞
7.3
7
*
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.1
7.3
74
349
9109
FHL
Other measure in this category
10.9
7.3
13
12
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
7.2
427
3251
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.1
7.2
21
41
ZX121
NOMESCO Finland
Central venous catheter
5.1
7.2
21
41
3AA02
NOMESCO Finland
NA
15.8
7.2
11
7
WE100
NOMESCO Finland
Profylactic cytostatic therapy
15.8
7.2
11
7
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
7.2
74
352
6BA02
NOMESCO Finland
NA
5.4
7.2
20
37
ZX130
NOMESCO Finland
Epidural
5.8
7.2
19
33
5702
FHL
Local lymph node removal (eg armpit, groin)
5.8
7.2
19
33
N03AX14
ATC
levetiracetam; systemic
2.2
7.2
69
320
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
30.1
7.1
9
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
30.1
7.1
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
7.1
473
3666
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
7.1
115
650
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
6.6
7.1
17
26
R59
ICD-10 Finland
Enlarged lymph nodes
12.0
7.1
12
10
1AA01
NOMESCO Finland
NA
12.0
7.1
12
10
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
8.8
7.0
14
16
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.5
7.0
53
218
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
7.0
7.0
16
23
RS220
NOMESCO Finland
NA
2.8
7.0
41
146
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
6.3
6.9
17
27
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.9
969
8282
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
5.2
6.9
20
39
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
6.9
1088
9419
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.2
6.9
34
108
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.2
6.9
67
312
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
7.5
6.9
15
20
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
13.8
6.9
11
8
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
13.8
6.9
11
8
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.8
381
2871
L03AA04
ATC
NA
8.3
6.8
14
17
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.6
6.8
46
179
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
6.8
112
636
6753
FHL
Transabdominal splenectomy
9.3
6.8
13
14
J94.0
ICD-10 Finland
Chylous effusion
40.1
6.8
8
*
1518
Kela drug reimbursment
NA
40.1
6.8
8
*
ZXC40
NOMESCO Finland
Use of ultrasound
3.7
6.7
27
73
JN5AP
NOMESCO Finland
Total body PET (1 picture)
16.7
6.7
10
6
5701
FHL
Local exploration of lymph nodes (includes biopsy)
16.7
6.7
10
6
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
6.7
416
3192
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.1
6.7
34
111
ZXC95
NOMESCO Finland
Use of surgical navigator
3.0
6.6
35
117
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.9
6.6
38
132
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
7.8
6.6
14
18
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
5.5
6.6
18
33
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
5.5
6.6
18
33
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
3.7
6.6
26
70
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
8.7
6.5
13
15
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
6.5
159
2342
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
6.5
127
758
PJD99
NOMESCO Finland
Excision of other lymph nodes
10.0
6.5
12
12
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.5
682
5629
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.7
6.5
134
816
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.7
6.5
40
148
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.1
6.5
23
56
H26.3
ICD-10 Finland
Drug-induced cataract
4.1
6.5
23
56
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.5
446
3475
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
2.4
6.4
50
210
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
70.0
6.4
7
*
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
70.0
6.4
7
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
70.0
6.4
7
*
1XX08
NOMESCO Finland
NA
70.0
6.4
7
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
70.0
6.4
7
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.9
6.4
35
121
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.6
6.3
166
1076
C10AA01
ATC
simvastatin; oral
0.8
6.3
1082
12267
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
6.5
6.3
15
23
WX704
NOMESCO Finland
Intubation
1.6
6.3
176
1156
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
11.0
6.3
11
10
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
18.0
6.3
9
5
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
+∞
6.2
6
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
1CB01
NOMESCO Finland
NA
+∞
6.2
6
*
AAF35
NOMESCO Finland
Implantation of reservoir for intraventricular therapy
+∞
6.2
6
*
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
6.2
6
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
6.2
6
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
6.2
6
*
1AD01
NOMESCO Finland
NA
+∞
6.2
6
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
6.2
6
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.1
6.2
31
100
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
26.7
6.2
8
*
2301
FHL
Lumbar puncture in anesthesia or operating room
26.7
6.2
8
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
26.7
6.2
8
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
26.7
6.2
8
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
6.2
90
491
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
7.0
6.2
14
20
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.1
35
122
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
3.9
6.1
23
60
JAL00
NOMESCO Finland
Biopsy of peritoneum
4.4
6.0
20
46
C07AB07
ATC
bisoprolol; oral
1.2
6.0
1432
12873
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
214
75
30.27
322.70
2.4
2.1
%
35.9
25.6
5.99
196
69
(3006245) CD3-CD19+ cells/100 cells in Blood
213
74
30.53
322.13
2.4
2.0
%
11.5
11.6
0.01
185
67
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2807
16010
4.41
320.87
15.7
6.2
umol/l
10.7
12.0
5.37
2769
15184
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
348
166
23.10
307.65
3.3
1.8
e6/l
441.3
712.8
4.10
139
71
(3013115) Eosinophils [#/volume] in Blood
2871
15119
5.42
307.65
11.4
5.9
e9/l
0.2
0.2
22.27
2646
13109
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
476
150
36.41
307.65
2.4
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2365
3781
16.29
307.65
8.3
4.0
u/l
279.7
239.5
7.10
2309
3561
(3017143) Hepatitis C virus Ab [Presence] in Serum
1642
2487
11.29
307.65
1.5
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2725
13358
5.26
307.65
11.0
6.0
%
0.7
0.7
0.81
2654
12401
(40768795) Lymph node Pathology biopsy report
808
220
47.05
307.65
1.4
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
447
187
27.15
307.65
2.4
1.9
%
28.0
43.0
3.07
50
24
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1514
1534
16.29
307.65
1.4
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2842
14575
5.49
307.65
10.5
5.7
e9/l
0.6
0.6
0.06
2598
12444
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
364
154
26.18
307.65
3.0
1.9
e6/l
575.8
519.0
0.35
302
127
(3019198) Lymphocytes [#/volume] in Blood
2854
14933
5.38
307.65
10.7
5.8
e9/l
1.9
1.9
0.36
2643
12988
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
412
433
10.61
307.65
1.4
1.4
u/ml
115.4
122.3
0.23
105
80
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
350
145
26.63
307.65
3.1
1.9
e9/l
0.2
0.2
0.22
302
125
(3045142) Bone marrow Pathology biopsy report
778
323
30.44
307.65
1.6
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
594
210
33.67
307.65
2.7
1.9
e9/l
1.1
1.0
0.49
411
113
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
620
540
13.66
307.65
5.0
5.2
iu/ml
2701.8
762.7
0.40
97
74
(3006315) Basophils [#/volume] in Blood
2848
14646
5.50
307.65
10.5
5.7
e9/l
0.0
0.0
13.48
2605
12525
(3006504) Eosinophils/100 leukocytes in Blood
2744
13714
5.19
307.65
11.3
6.0
%
2.6
2.9
5.84
2674
12707
(21494814) CD8 cells/100 lymphocytes in Specimen
279
81
37.25
307.65
2.1
1.9
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
329
11
329.04
307.65
8.5
18.3
umol/l
0.4
0.4
0.22
320
11
(3042111) Morphology [Interpretation] in Bone marrow Narrative
765
547
17.48
307.65
1.7
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2755
13777
5.24
307.65
11.8
6.3
%
9.7
8.9
23.72
2683
12819
(3026493) Urate [Moles/volume] in Serum or Plasma
2197
8146
5.35
307.65
6.2
2.8
umol/l
807.2
6013.2
15.75
2125
6927
(3010503) CD19 cells [#/volume] in Blood
389
138
31.48
307.65
2.8
1.9
e9/l
0.2
0.2
0.20
383
130
(3018010) Neutrophils/100 leukocytes in Blood
2714
13854
4.88
307.65
10.5
5.9
%
56.3
58.1
9.45
2642
12871
(3002030) Lymphocytes/100 leukocytes in Blood
2759
14065
5.10
307.65
11.6
6.1
%
27.1
26.6
1.08
2687
13002
(42870588) Differential panel, method unspecified - Blood
2366
10275
4.79
307.65
10.4
5.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
254
78
34.96
307.65
1.2
1.1
—
—
—
0
0
(4035726)
1399
2677
7.91
307.65
1.7
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1750
3220
9.62
307.65
1.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
1212
2096
8.21
307.65
4.3
2.7
g/l
8.7
10.7
29.51
1163
1899
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
254
66
41.33
307.65
2.2
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
486
153
36.56
307.65
2.3
2.0
%
14.8
13.5
0.44
194
67
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
675
158
52.34
307.65
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1231
3958
4.20
307.65
3.8
2.5
%
1.8
1.8
0.08
1157
3477
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
462
494
10.58
307.65
1.4
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
542
425
14.83
307.65
2.6
2.6
u/ml
4750.9
1194.7
1.08
42
32
(3023520) Reticulocytes [#/volume] in Blood
1041
2991
4.49
307.65
3.8
2.5
e9/l
69.7
69.0
0.24
878
2275
(3017181) Myelocytes/100 leukocytes in Blood
1007
2594
5.00
307.65
6.2
4.0
%
1.2
0.9
2.04
635
738
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
319
144
24.21
307.65
3.9
2.4
%
33.1
41.5
3.59
125
49
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1678
2714
10.70
307.65
1.5
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
490
159
35.51
307.65
2.3
1.9
%
73.2
70.2
1.14
469
147
(3028026) IgM [Mass/volume] in Serum or Plasma
868
1662
6.56
307.65
3.2
1.8
g/l
1.6
1.3
1.23
816
1498
(3013650) Neutrophils [#/volume] in Blood by Automated count
2938
17039
4.92
307.65
26.3
8.7
e9/l
3.5
4.3
62.57
2745
14783
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
479
732
7.39
305.43
2.3
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
881
2356
4.63
305.42
6.0
3.8
%
0.7
0.6
1.14
443
514
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
484
762
7.18
300.09
2.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
894
2475
4.47
295.58
6.4
4.0
%
0.2
0.1
3.71
578
687
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1386
5224
3.69
295.32
7.2
3.2
mmol/l
0.8
0.8
2.17
1335
4861
(3024561) Albumin [Mass/volume] in Serum or Plasma
2486
13606
3.67
289.06
8.8
4.9
g/l
33.8
34.9
16.27
2400
12622
(3004809) Band form neutrophils/100 leukocytes in Blood
401
542
8.20
284.45
4.8
3.5
%
1.5
1.7
0.43
334
405
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
400
563
7.87
273.78
2.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
477
825
6.51
269.27
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
262
236
11.89
251.45
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
815
2384
4.13
246.64
2.3
2.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
257
243
11.31
238.66
1.7
1.8
mg/l
4.0
4.6
0.98
244
233
(3000060) B lymphocytes [#/volume] in Blood
149
46
33.75
233.18
2.4
1.9
e6/l
646.7
198.9
0.55
52
19
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
332
463
7.80
228.25
1.3
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
123
19
66.99
224.63
1.8
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1822
9240
2.97
220.89
8.3
4.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
760
2321
3.88
214.11
6.3
4.1
%
0.1
0.3
0.61
457
572
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1106
4319
3.25
211.97
7.1
6.0
mmol/l
1.0
1.0
0.74
1071
4002
(3048929) Epstein Barr virus Ab [Presence] in Serum
373
644
6.35
209.54
1.4
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
338
543
6.77
203.69
1.9
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
300
431
7.50
200.46
1.3
1.2
u/ml
288.9
270.7
0.33
182
260
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2527
15821
3.00
198.05
12.7
7.0
mmol/l
1.2
1.2
9.25
2136
13301
(3020630) Protein [Mass/volume] in Serum or Plasma
832
2861
3.48
194.41
2.7
2.6
g/l
64.2
66.2
7.90
789
2595
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
296
459
6.94
184.15
1.9
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2337
14390
2.78
182.43
11.0
6.2
mmol/l
1.2
1.2
7.01
2253
12968
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
142
75
19.67
182.09
3.8
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1305
6011
2.84
181.62
9.8
4.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
289
445
6.97
180.94
1.8
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
246
324
8.08
176.99
2.3
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
237
300
8.39
176.27
2.4
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
252
350
7.67
173.15
5.4
4.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1201
5460
2.80
169.37
2.9
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
698
2330
3.48
169.03
2.3
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
204
233
9.22
164.60
1.3
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
252
374
7.17
163.02
1.9
1.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
86
11
80.07
161.20
1.1
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
115
49
24.21
161.10
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
454
1169
4.30
159.54
2.3
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1694
9339
2.54
158.86
8.6
4.1
ph
7.4
7.4
1.20
415
1816
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
266
434
6.54
157.23
1.9
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
169
160
11.03
156.20
4.3
3.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1817
10446
2.49
154.26
7.3
3.4
mmol/l
2.3
2.4
0.35
1694
9000
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
191
219
9.15
153.56
2.6
2.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
277
488
6.07
151.52
2.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
185
210
9.23
149.86
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1078
4938
2.69
146.46
2.5
1.5
g/l
2.0
2.6
12.05
877
2881
(3017354) Segmented neutrophils/100 leukocytes in Blood
227
339
7.08
145.81
4.9
3.5
%
54.4
57.4
0.75
153
205
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
122
77
16.36
143.41
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1204
5885
2.57
142.57
5.3
3.1
mmol/l
2.5
2.5
4.04
1161
5141
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
883
3792
2.76
134.86
2.6
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
881
3802
2.74
133.07
2.5
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
93
38
25.10
132.19
1.5
1.3
—
—
—
0
0
(44790049)
215
339
6.68
131.07
1.8
1.4
—
—
—
0
0
(44790047)
215
339
6.68
131.07
1.8
1.4
—
—
—
0
0
(44790048)
215
339
6.68
131.07
1.8
1.4
—
—
—
0
0
(44806118)
215
339
6.68
131.07
1.8
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2148
13952
2.34
130.00
7.2
4.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
314
711
4.74
129.21
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2030
12904
2.31
128.90
19.1
10.2
e9/l
0.0
0.0
1.05
1738
10529
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
121
93
13.43
127.52
1.9
1.9
u/ml
5196.4
36780.2
0.43
16
13
(3037756) Immunofixation for Serum or Plasma
320
744
4.62
127.41
1.4
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1644
9645
2.30
125.45
4.6
2.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3026
23202
2.90
123.16
20.4
7.7
u/l
83.7
80.0
3.81
2970
21804
(40758558) Short blood count panel - Blood
1369
7481
2.34
123.03
19.4
6.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2883
21653
2.66
120.91
7.1
4.2
mm/h
16.9
13.4
19.25
2779
19885
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
313
749
4.48
120.03
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
183
267
7.17
119.87
2.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
183
267
7.17
119.87
2.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
183
267
7.17
119.87
2.7
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
193
314
6.44
113.98
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
423
1342
3.44
108.43
2.6
2.5
g/l
7.3
7.4
0.76
330
1009
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
422
1341
3.43
107.88
2.6
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
421
1340
3.43
107.33
2.6
2.5
g/l
3.7
3.8
0.32
324
967
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
381
1138
3.63
107.14
2.7
2.5
g/l
1.4
1.1
0.71
337
982
(3037692) Legionella sp identified in Specimen by Organism specific culture
116
110
10.86
106.87
1.4
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
439
1441
3.33
106.50
2.7
1.9
ug/l
2.7
2.4
0.11
409
1266
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
396
1245
3.45
102.77
2.7
2.5
g/l
3.3
3.1
3.05
327
992
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
133
162
8.49
101.65
1.2
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
369
1119
3.56
101.23
2.7
3.5
mg/l
38.5
65.6
1.21
300
906
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1298
7416
2.17
100.11
4.3
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
367
1119
3.54
99.80
2.7
3.5
mg/l
58.0
57.3
0.03
301
902
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
73
33
22.56
99.65
1.5
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
114
117
10.03
99.32
3.1
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
113
115
10.11
99.05
3.1
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
113
115
10.11
99.05
3.1
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
390
1266
3.33
95.96
2.6
2.5
g/l
9.5
10.3
1.94
352
1076
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
355
1088
3.51
95.66
2.7
3.5
ratio
7.5
3.0
0.34
22
83
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
337
1004
3.60
94.80
2.6
2.4
g/l
0.1
0.0
0.36
323
916
(3018677) aPTT in Platelet poor plasma by Coagulation assay
978
5134
2.24
91.86
3.1
2.1
s
29.4
30.0
1.98
950
4979
(3042936) Bacteria identified in Isolate by Culture
888
4488
2.30
91.32
2.0
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1974
13513
2.02
90.47
10.4
10.6
inr
1.2
1.3
4.95
540
3755
(3042631) Mycobacterium sp identified in Specimen
214
480
4.68
88.58
2.1
2.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1306
7764
2.07
88.29
5.9
4.1
%
85.4
86.0
0.38
1277
7588
(3016650) Hepatitis A virus Ab [Presence] in Serum
190
390
5.09
87.40
1.1
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
120
155
7.97
87.32
3.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
120
155
7.97
87.32
3.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
120
155
7.97
87.32
3.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
120
155
7.97
87.32
3.1
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1768
11746
1.99
87.08
2.6
2.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
260
691
3.98
86.16
1.9
1.3
mg/l
626.0
544.3
1.48
252
650
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
141
225
6.48
84.70
2.1
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
131
194
6.97
84.47
2.2
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
306
925
3.52
83.95
2.8
2.4
g/l
0.0
0.0
0.00
296
855
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
308
939
3.49
83.38
2.8
2.4
g/l
0.0
0.0
0.07
296
856
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
156
280
5.78
83.19
2.2
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
236
600
4.14
83.07
2.1
1.5
e6/l
8805.1
853.4
0.46
208
491
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
236
600
4.14
83.07
2.0
1.4
e6/l
23.5
25.3
0.05
204
464
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
130
195
6.88
82.83
2.2
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
328
1047
3.35
82.56
2.7
2.3
g/l
36.5
37.5
1.89
305
900
(3044290) Cell count panel - Cerebral spinal fluid
221
544
4.26
81.19
2.0
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
433
1642
2.86
80.84
2.1
1.7
g/l
1.6
1.5
0.20
361
1409
(40760888) Immunoglobulin light chains.free panel - Serum
283
849
3.53
78.44
2.7
3.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
282
851
3.51
77.44
3.4
2.5
g/l
3.8
3.5
1.30
273
805
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
311
1004
3.30
76.73
1.7
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
695
3405
2.29
75.37
4.6
2.8
umol/l
7.7
9.3
1.25
627
2995
(3013826) Glucose [Moles/volume] in Serum or Plasma
2405
18313
1.94
73.48
8.0
4.9
mmol/l
6.7
6.9
3.82
2339
17234
(3019832) Treponema pallidum Ab [Presence] in Serum
329
1162
3.02
69.52
1.4
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
71
62
11.66
68.97
2.5
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
219
611
3.75
67.50
1.9
1.3
mmol/l
3.7
3.9
1.31
208
571
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
181
441
4.27
67.28
6.0
6.7
mg/l
11.2
12.1
2.14
166
412
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
51
25
20.68
67.16
1.8
2.5
mg/l
1.5
1.1
0.27
32
20
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
94
124
7.76
67.14
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
148
308
4.97
66.89
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
172
409
4.37
65.98
1.1
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
210
586
3.74
64.68
6.8
3.4
%
56.5
57.9
0.62
210
586
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
54
33
16.60
64.24
1.4
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
80
92
8.87
63.91
1.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
52
30
17.57
63.62
1.1
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1189
7495
1.88
63.02
1.6
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
145
322
4.65
60.60
3.5
2.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
103
174
6.06
58.41
1.7
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
271
946
3.02
58.23
1.7
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1292
8532
1.80
57.75
3.8
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1331
8872
1.79
57.61
3.8
3.3
e6/l
0.5
0.5
0.02
1043
6773
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
102
174
6.00
57.28
1.7
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1479
10197
1.76
56.78
3.7
3.2
ng/l
1854.8
1631.1
1.13
1357
8829
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
61
57
10.87
56.63
1.7
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2472
19728
1.81
56.58
5.5
4.8
e6/l
1422.5
1602.1
0.06
46
318
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
172
459
3.88
56.42
1.3
1.3
miu/ml
129.0
216.2
1.65
30
178
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
434
1952
2.39
56.27
1.8
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1421
9735
1.76
55.41
3.9
3.4
e6/l
35.6
81.2
3.94
1140
7595
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
786
4481
1.96
55.41
2.5
2.7
%
23.6
22.4
1.21
704
3812
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
226
730
3.24
55.39
2.0
1.8
mg/l
11.3
11.8
0.35
216
665
(3004789) Transferrin [Mass/volume] in Serum or Plasma
817
4739
1.94
54.63
2.4
2.6
g/l
2.2
2.3
7.41
768
4391
(3018095) Leukocytes [#/volume] in Urine
1561
11035
1.73
54.05
4.5
3.9
e6/l
137.7
117.2
0.18
1193
8075
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
647
3474
2.05
53.88
2.3
4.0
ug/l
10.5
21.5
1.29
452
2890
(3022948) Iron [Moles/volume] in Serum or Plasma
854
5099
1.88
51.94
2.5
2.6
umol/l
12.9
12.5
0.53
806
4732
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
100
185
5.53
51.57
2.9
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1209
8131
1.73
48.81
2.2
2.3
mg/l
3.4
3.0
3.44
1048
6902
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
304
1247
2.57
47.82
3.4
3.0
u/ml
0.4
0.3
0.32
194
708
(3000991) Gas panel - Venous blood
538
2823
2.06
47.22
8.3
8.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
105
233
4.61
43.92
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
618
3488
1.93
43.83
1.8
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
54
62
8.83
43.16
1.4
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
573
3171
1.96
43.00
5.6
3.8
mmol/l
2.0
2.0
0.03
474
2555
(3016018) Differential panel - Cerebral spinal fluid
116
284
4.19
42.80
1.9
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
112
267
4.30
42.79
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
49
51
9.73
42.15
2.3
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
61
84
7.37
41.96
1.6
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
285
1208
2.48
41.71
1.9
1.8
u/l
43.1
38.2
2.81
254
1033
(3012544) pH of Venous blood
584
3300
1.92
41.05
5.6
3.8
ph
7.4
7.4
—
5
18
(3000850) Epithelial cells [#/volume] in Urine
1024
6842
1.69
40.87
3.1
2.7
e6/l
3.8
4.8
3.47
926
5994
(3021447) Carbon dioxide [Partial pressure] in Venous blood
567
3182
1.93
40.65
5.7
3.8
kpa
5.7
5.8
2.28
556
3075
(3020779) Urea [Moles/volume] in Serum or Plasma
561
3139
1.93
40.58
7.8
7.3
mmol/l
10.3
10.5
0.24
546
2978
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
52
63
8.36
39.83
1.8
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
54
69
7.93
39.60
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
494
2675
1.98
39.24
10.6
4.0
mmol/l
1.2
1.2
1.01
482
2352
(3009343) pH of Capillary blood
424
2181
2.07
38.84
4.7
3.8
ph
7.4
7.4
3.00
58
281
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
413
2104
2.09
38.83
4.6
3.7
mmol/l
2.3
1.8
2.20
343
1527
(3026782) Osmolality of Urine
963
6410
1.69
38.60
3.3
2.9
mosm/kgh2o
537.4
552.2
1.51
867
5454
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
426
2213
2.05
37.95
4.7
3.8
kpa
5.0
5.2
2.99
409
2039
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
184
662
2.88
37.27
1.2
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1547
11666
1.57
36.77
3.2
2.9
ug/l
400.6
152.9
19.50
1440
10618
(3025941) Bacteria identified in Stool by Culture
313
1462
2.25
36.60
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
274
1224
2.34
35.57
2.0
3.2
u/ml
207.8
4340.8
1.11
220
1044
(3009871) Measles virus Ab [Titer] in Serum
49
64
7.75
35.27
1.9
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
83
183
4.62
35.02
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
103
268
3.93
35.01
1.5
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1306
9595
1.57
34.07
2.9
2.6
u/l
52.5
58.9
4.88
1212
8835
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
791
5146
1.69
33.92
3.3
3.1
e6/l
1.7
1.9
0.31
448
2889
(3037467) Urinalysis macro (dipstick) panel - Urine
2422
20406
1.57
33.72
5.4
4.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
928
6318
1.63
33.24
2.2
1.7
mg/l
2.0
1.4
2.22
755
4922
(3025468) Yersinia sp identified in Specimen by Organism specific culture
125
384
3.34
33.19
2.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
125
384
3.34
33.19
2.7
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
179
675
2.74
33.17
2.3
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
47
63
7.55
33.10
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
125
386
3.32
32.91
2.7
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
824
5471
1.66
32.50
3.2
2.9
e6/l
1.0
1.1
0.71
477
3192
(3024522) Salmonella sp identified in Specimen by Organism specific culture
125
390
3.28
32.37
2.7
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
67
132
5.15
32.28
3.3
5.9
u/ml
39.6
58.3
—
5
33
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
124
388
3.27
31.97
2.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
125
394
3.25
31.84
2.7
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
47
66
7.20
31.78
1.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
463
2628
1.87
31.54
2.1
2.2
nmol/l
371.4
371.2
0.01
443
2392
(3014111) Lactate [Moles/volume] in Serum or Plasma
510
2989
1.82
31.35
7.4
6.9
mmol/l
1.5
1.4
1.72
494
2867
(3026008) Bacteria identified in Urine by Culture
1276
9466
1.54
31.16
3.6
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
931
6429
1.60
31.13
4.2
3.9
ng/l
319.4
561.8
0.52
813
5389
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
319
1607
2.08
30.66
6.9
4.1
mmol/l
24.6
24.2
1.12
298
1438
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
73
162
4.58
30.58
2.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
73
162
4.58
30.58
2.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
385
2077
1.96
30.55
2.2
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
286
1387
2.15
30.35
3.4
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
104
301
3.53
30.31
1.3
2.1
u/l
157.3
2576.7
1.88
27
119
(3014576) Chloride [Moles/volume] in Serum or Plasma
665
4253
1.69
29.99
9.2
6.8
mmol/l
104.3
104.4
0.22
642
4151
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
196
816
2.48
29.70
6.2
3.5
mg/l
1.5
1.7
1.27
181
736
(3022313) Gas panel - Capillary blood
312
1578
2.07
29.64
5.2
3.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
130
441
3.02
29.27
1.8
2.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
74
173
4.35
29.05
3.0
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
503
3006
1.78
28.82
2.2
2.2
g/l
0.2
0.2
4.38
465
2803
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
26
18
14.54
28.79
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
85
222
3.90
28.78
2.1
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
93
264
3.59
27.92
1.5
1.4
g/l
2.1
3.0
4.05
65
184
(3024139) IgG subclass 3 [Mass/volume] in Serum
93
264
3.59
27.92
1.5
1.4
g/l
0.3
0.4
1.80
64
185
(3027135) IgG subclass 1 [Mass/volume] in Serum
93
264
3.59
27.92
1.5
1.4
g/l
6.0
6.8
0.79
63
185
(3017732) Neutrophils [#/volume] in Blood
355
1926
1.94
27.60
3.1
3.3
e9/l
4.0
4.2
0.36
260
1421
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
130
456
2.92
27.59
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
83
220
3.84
27.53
2.1
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1554
12248
1.47
27.21
4.6
4.0
ng/l
40.7
91.7
0.80
1311
9230
(3002256) Pathology report gross observation
619
3978
1.67
27.16
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
140
517
2.78
27.02
1.7
1.5
g/l
31.2
31.7
0.17
132
465
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
109
350
3.18
26.96
1.4
1.3
u/l
364.6
324.5
0.28
98
334
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1515
11897
1.47
26.94
2.4
2.2
nmol/l
78.6
78.6
0.02
1408
10476
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
124
435
2.92
26.32
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
267
1331
2.09
26.31
5.6
4.1
mmol/l
25.7
24.8
4.90
253
1225
(3024980) IgG subclass 4 [Mass/volume] in Serum
121
421
2.94
26.07
1.5
1.7
g/l
0.5
0.9
4.44
85
320
(4062490)
91
267
3.47
26.01
1.5
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
565
3586
1.68
25.89
1.9
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
540
3392
1.70
25.71
6.1
3.6
—
—
—
0
0
(3019225) pH of Specimen
525
3283
1.70
25.40
7.7
4.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1220
9262
1.48
25.34
6.4
3.2
u/l
36.0
38.4
0.43
1165
8780
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
32
38
8.49
24.88
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
89
267
3.39
24.59
2.6
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3123
28667
1.67
23.66
39.6
16.2
mg/l
24.7
26.2
1.91
2915
23169
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
252
1283
2.04
23.43
2.4
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
182
817
2.29
23.29
1.5
1.6
iu/ml
1.3
12.7
0.79
46
169
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
154
658
2.40
22.07
1.4
1.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
21
16
13.20
21.97
2.3
6.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
110
400
2.81
21.90
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
111
408
2.78
21.66
1.6
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
56
133
4.26
21.60
1.5
1.2
%
66.6
65.1
0.04
11
16
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
446
2788
1.68
21.39
2.4
2.4
u/l
36.8
55.7
0.56
382
2375
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
160
720
2.28
20.38
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
160
720
2.28
20.38
1.5
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
42
83
5.11
20.23
1.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
41
80
5.17
20.03
1.3
1.2
%
16.3
23.9
0.26
14
11
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
170
791
2.21
19.98
3.9
2.5
%
226.8
198.6
3.16
161
758
(3036489) Thrombin time
215
1095
2.02
19.95
3.3
2.1
s
22.8
21.6
1.22
202
994
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
121
487
2.54
19.74
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
40
81
4.98
18.75
1.4
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
9
27.95
18.70
1.7
3.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
80
270
3.01
18.27
1.3
1.3
u/l
32.7
12.1
1.25
75
247
(3001686) Cold agglutinin [Titer] in Serum or Plasma
34
61
5.62
18.19
1.7
1.3
titre
45.0
128.7
—
7
9
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
160
758
2.16
17.99
1.7
1.5
g/l
0.2
0.2
1.31
145
722
(3003396) Base excess in Arterial blood by calculation
576
3986
1.53
17.87
9.2
7.1
mmol/l
1.5
1.1
1.52
450
3094
(40768797) Stomach Pathology biopsy report
594
4143
1.52
17.76
1.4
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
574
3989
1.52
17.43
9.2
7.1
kpa
12.2
12.1
0.33
548
3795
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
31
7.79
17.42
1.4
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
574
3990
1.52
17.41
9.2
7.1
kpa
5.0
5.1
2.43
543
3794
(3016502) Oxygen saturation in Arterial blood
528
3609
1.54
17.30
9.8
7.4
%
95.9
95.4
1.57
508
3469
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
162
785
2.11
17.20
1.7
1.5
g/l
1.1
1.2
1.31
156
745
(3023199) Leukocytes [#/volume] in Pleural fluid
110
454
2.47
17.06
1.6
1.4
e6/l
2074.9
1828.6
0.28
75
328
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
29
7.98
17.02
1.3
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
29
7.98
17.02
1.3
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
29
7.98
17.02
1.3
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
103
415
2.53
16.81
1.5
1.4
e6/l
25807.9
82287.0
1.69
58
241
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
67
216
3.14
16.58
1.4
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
92
359
2.60
16.05
1.5
1.4
mmol/l
6.1
6.5
0.74
85
335
(3019060) Gas panel - Arterial blood
364
2327
1.63
15.82
7.9
4.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
120
534
2.29
15.75
1.7
1.4
u/l
10.5
9.6
0.30
104
432
(1616796) Gas panel - Central venous blood
157
778
2.06
15.73
3.9
4.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
43
108
4.02
15.48
2.0
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
44
113
3.93
15.37
1.2
1.1
ng/l
2092.4
433.4
0.88
21
31
(3024354) Oxygen [Partial pressure] in Venous blood
397
2620
1.58
15.09
5.6
3.2
kpa
4.7
4.5
0.56
385
2525
(21494890) Protein electrophoresis panel - 24 hour Urine
93
377
2.51
15.02
1.9
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
206
1142
1.85
14.89
2.4
3.6
u/ml
98.7
75.4
0.47
198
1097
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
20
25
8.04
14.89
3.5
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
20
25
8.04
14.89
1.7
3.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
49
140
3.53
14.71
1.3
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
20
8
25.12
14.67
1.6
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2029
17802
1.32
14.50
4.0
3.2
u/l
62.5
55.0
2.09
1888
16300
(3002173) Hemoglobin [Mass/volume] in Arterial blood
474
3296
1.50
14.17
10.6
7.8
g/l
111.8
121.1
17.96
455
3175
(40761536) Microorganisms panel - Urine sediment
377
2495
1.57
14.13
4.8
4.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
151
772
2.00
13.92
4.3
4.9
mmol/l
2.8
2.7
0.14
116
542
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
64
223
2.90
13.90
1.1
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
24
40
6.03
13.85
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
978
7770
1.36
13.79
1.6
1.6
nmol/l
19.3
20.3
1.20
852
6558
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
157
818
1.96
13.71
1.2
1.4
—
17.0
—
0
19
(3035350) Ketones [Presence] in Urine by Test strip
1664
14277
1.31
13.65
4.3
3.8
estimate
0.0
0.0
0.00
411
2698
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
479
3367
1.49
13.55
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
148
3.34
13.53
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
14
12
11.71
13.53
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
41
5.89
13.51
1.3
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
24
41
5.89
13.51
13.0
3.3
umol/l
44.9
40.6
0.37
19
33
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
84
4.20
13.40
1.9
1.5
ug/l
1.5
3.0
2.04
24
61
(3024891) Influenza virus A+B Ag [Presence] in Specimen
136
680
2.04
13.34
1.3
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
55
180
3.09
13.33
1.2
1.1
mg/l
72.7
40.2
2.07
43
149
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
186
1035
1.84
13.31
1.6
1.6
titre
435.0
272.7
—
7
55
(3020393) Adenovirus Ag [Presence] in Stool
19
26
7.34
13.12
1.7
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
29
61
4.78
13.06
1.7
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
70
265
2.67
13.04
1.3
1.1
u/ml
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
77
306
2.55
13.01
1.2
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
45
132
3.44
13.01
31.8
26.5
ug/l
106.5
115.9
0.46
38
109
(3037522) Nuclear Ab [Titer] in Serum
491
3496
1.47
12.99
1.3
1.3
titre
745.7
520.4
1.19
109
758
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
526
2.17
12.96
1.7
1.4
iu/l
28.9
30.1
0.13
93
442
(3010937) Rubella virus Ab [Presence] in Serum
17
6
28.45
12.95
1.1
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
18
8
22.60
12.88
1.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
20
30
6.70
12.74
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2535
23136
1.32
12.68
43.3
19.8
%
14.5
13.8
81.99
2510
22583
(3035880) pH of Pleural fluid
60
213
2.85
12.63
1.5
1.3
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
15
16
9.41
12.54
1.1
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
265
1662
1.64
12.40
3.8
3.4
mmol/l
25.1
25.2
0.20
259
1608
(3015235) Bicarbonate [Moles/volume] in Capillary blood
170
941
1.85
12.38
3.1
3.2
mmol/l
24.3
24.9
0.88
155
819
(3026389) Candida sp identified in Specimen by Organism specific culture
84
358
2.38
12.24
1.4
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
52
175
3.00
12.05
1.2
1.0
mg/l
424.6
296.9
1.25
44
151
(46236302) HLA-C [Type] by High resolution typing
17
8
21.34
11.99
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
17
8
21.34
11.99
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
17
8
21.34
11.99
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
17
8
21.34
11.99
1.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
22
39
5.67
11.94
1.8
1.2
ng/l
81.0
112.9
0.19
17
25
(21491868) Cryoglobulin [Mass/volume] in Serum
39
111
3.54
11.83
1.9
1.2
g/l
1.6
0.1
—
8
9
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.46
1.0
0.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
18
27
6.70
11.46
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
32
81
3.98
11.46
1.6
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
26
56
4.67
11.40
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1645
14306
1.28
11.36
5.7
5.1
estimate
0.0
0.0
0.50
420
2725
(3010421) pH of Blood
162
908
1.82
11.36
4.3
4.7
ph
7.4
7.4
1.75
149
760
(3028626) Oxygen [Partial pressure] in Capillary blood
153
845
1.85
11.25
3.4
3.1
kpa
8.0
8.0
0.07
145
774
(3001893) Eosinophils/100 leukocytes in Pleural fluid
42
130
3.26
11.21
2.0
1.5
%
2.1
2.6
0.15
36
112
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2604
27859
0.76
11.06
4.3
4.7
mmol/l
1.4
1.4
15.00
2326
25235
(3008152) Bicarbonate [Moles/volume] in Arterial blood
324
2188
1.53
11.05
10.9
6.8
mmol/l
24.9
24.5
0.79
302
2043
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
98
466
2.13
11.04
1.2
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
46
152
3.05
11.03
1.9
1.4
%
66.4
67.8
0.09
39
124
(3021901) Oxygen saturation in Capillary blood
131
694
1.92
10.96
3.1
2.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
50
174
2.90
10.95
1.6
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1659
14486
1.27
10.93
4.4
3.9
estimate
0.0
0.0
0.22
405
2630
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
245
1557
1.62
10.88
4.7
2.6
%
0.7
0.6
1.40
237
1489
(3052851) Hemolysis interference index of Serum or Plasma
164
936
1.79
10.84
4.0
3.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
39
118
3.33
10.80
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
27
63
4.31
10.75
1.1
1.2
mmol/l
3.4
2.2
0.33
20
45
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2520
27048
0.77
10.74
5.8
6.4
mmol/mol
40.5
40.6
0.28
2266
24718
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
150
3.03
10.64
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
807
6439
1.33
10.62
1.8
1.8
nmol/l
1210.2
1171.4
0.54
640
4800
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2635
28103
0.77
10.53
4.4
4.7
mmol/l
4.5
4.5
1.93
2380
25649
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
47
162
2.93
10.49
1.2
1.0
—
—
—
0
0
(3013512) EKG study
1129
9442
1.29
10.44
5.0
4.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
215
1339
1.64
10.36
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
8
18.82
10.25
1.5
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
24
53
4.55
10.23
1.3
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
23
49
4.72
10.23
1.2
1.3
—
—
—
0
0
(3024316) Viscosity of Plasma
14
18
7.80
10.14
2.9
1.4
mpas
1.7
1.6
—
7
9
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
69
294
2.37
10.13
1.2
1.2
u/l
57.5
58.5
0.05
55
197
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2711
28772
0.77
10.11
4.8
5.3
mmol/l
2.6
2.6
0.29
2418
26104
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
234
1499
1.60
10.07
2.6
3.3
pmol/l
4.2
4.4
2.60
211
1299
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
425
3084
1.43
10.06
3.2
3.0
ng/l
278.5
217.8
1.58
394
2828
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
100
497
2.04
10.06
1.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
79
359
2.23
9.99
1.5
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
17
28
6.10
9.92
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
608
4697
1.35
9.88
26.8
28.2
inr
1.3
1.4
0.84
91
652
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
620
7851
0.75
9.74
1.7
1.6
mmol/l
1.4
1.4
1.43
528
6495
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
14
19
7.39
9.70
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
280
1885
1.53
9.69
13.8
9.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
348
2450
1.47
9.68
3.7
4.0
ng/l
88.5
96.5
0.80
295
2094
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
68
296
2.32
9.53
1.2
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
36
113
3.21
9.44
28.4
31.2
ug/l
7.0
7.2
0.28
29
98
(3027974) Hepatitis B virus e Ag [Presence] in Serum
12
14
8.60
9.34
1.3
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
135
763
1.80
9.27
3.4
2.6
%
14.6
16.1
4.39
77
399
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
131
739
1.80
9.06
2.1
3.4
u/ml
738.9
747.2
0.00
116
679
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
11
12
9.19
8.98
1.7
1.2
mg/l
0.1
1.8
—
5
6
(3006922) Hepatitis E virus Ab [Presence] in Serum
44
160
2.77
8.96
1.1
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
82
3.56
8.94
1.1
1.1
miu/ml
905.1
1623.7
3.34
29
82
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
42
150
2.82
8.84
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
42
150
2.82
8.84
1.1
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1686
14987
1.23
8.73
2.9
2.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
234
1552
1.54
8.68
4.5
4.0
%
49.2
48.4
0.20
234
1532
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
56
234
2.42
8.63
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
131
2.92
8.53
1.4
5.9
mg/l
69.8
64.8
0.09
32
92
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1141
9740
1.25
8.50
2.2
2.2
u/l
163.5
217.8
1.87
1081
9104
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
11
13
8.48
8.46
1.7
1.2
mg/l
1.9
2.9
—
5
7
(3017704) Immunofixation for Urine
49
195
2.53
8.38
1.4
1.6
—
—
—
0
0
(3020891) Body temperature
208
1359
1.56
8.26
6.1
4.6
—
—
—
0
0
(4027681)
38
134
2.86
8.21
1.3
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
33
108
3.07
8.12
1.4
1.3
ug/l
1.4
449.4
1.11
14
56
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
19
42
4.54
8.11
1.7
2.0
ng/l
117.4
114.2
0.04
11
22
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
38
135
2.83
8.10
1.3
1.0
u/l
1.2
1.2
0.03
22
70
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
7
17.20
8.07
1.7
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
112
626
1.81
8.02
1.2
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
11
5
22.06
8.01
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
135
801
1.71
7.88
1.4
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
73
356
2.07
7.81
3.3
3.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
136
811
1.70
7.80
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
2279
21035
1.23
7.78
5.0
4.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
24
66
3.65
7.73
2.0
1.5
%
4.8
5.0
0.03
13
33
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2863
27105
1.27
7.72
33.1
15.4
ml/min/173m2
76.7
76.0
0.93
2605
22464
(3029937) Albumin [Presence] in Urine by Test strip
934
7865
1.25
7.71
5.0
4.2
estimate
0.0
0.0
0.31
391
2581
(3022145) Colonoscopy Study observation
434
3303
1.36
7.69
1.4
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
26
76
3.44
7.66
1.9
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
136
816
1.69
7.64
1.4
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
11
15
7.35
7.55
1.4
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
20
49
4.10
7.53
1.3
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
131
782
1.70
7.50
2.7
2.2
g/l
119.3
128.3
3.44
96
573
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
12
9
13.37
7.38
1.2
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
187
1225
1.56
7.37
4.9
3.8
mmol/l
1.6
1.4
0.92
181
1206
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
0
+∞
7.29
1.0
0.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
74
3.39
7.24
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
128
768
1.69
7.21
1.9
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
237
1644
1.47
7.13
1.3
1.3
au/ml
83.8
56.3
—
6
74
(3037121) Protein [Mass/volume] in Urine
171
1109
1.57
7.06
2.8
3.1
g/l
0.7
0.3
0.75
85
458
(3047181) Lactate [Moles/volume] in Blood
166
1070
1.58
7.04
12.0
6.2
mmol/l
1.3
1.3
0.03
140
943
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
11
8
13.79
6.88
1.1
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
11
8
13.79
6.88
1.1
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
260
1851
1.44
6.84
9.2
9.1
mmol/l
24.4
24.3
0.12
246
1722
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
108
628
1.74
6.83
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2554
26963
0.82
6.61
4.0
4.2
mmol/l
1.3
1.3
2.35
2282
24210
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
79
3.18
6.56
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
64
320
2.02
6.47
1.2
1.2
u/ml
61.3
47.2
—
6
17
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
43
185
2.34
6.31
2.9
3.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
254
1831
1.42
6.25
2.5
2.4
au/ml
38.0
22.5
—
5
73
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
334
2524
1.36
6.19
3.4
2.8
ml/min/173m2
58.7
62.4
0.87
134
1062
(3051651) Icteric interference index of Serum or Plasma
41
175
2.36
6.13
5.2
3.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3128
30131
1.29
6.11
38.7
19.2
mmol/l
139.4
139.6
7.57
3088
29349
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1470
13196
1.19
6.08
2.1
2.1
pmol/l
91.0
93.5
1.20
860
6870
(3005322) IgE [Units/volume] in Serum or Plasma
215
1512
1.45
6.07
1.3
1.3
u/ml
539.3
231.3
1.03
186
1389
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
33
128
2.59
6.03
1.5
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
116
714
1.65
5.99
2.5
2.7
umol/l
33.0
36.1
0.61
101
594
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
17
44
3.88
5.98
1.2
1.2
%
68.4
55.9
0.49
11
15
(3051611) Lipemic interference index of Serum or Plasma
61
309
1.99
5.98
4.3
3.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
31
118
2.64
5.89
1.3
1.4
mmol/l
3.5
3.3
0.12
31
107
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
34
137
2.50
5.77
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
96
568
1.71
5.76
1.3
1.2
u/ml
1.4
7.6
—
7
42
(3041918) Cholesterol [Moles/volume] in Pleural fluid
23
75
3.08
5.76
1.1
1.2
mmol/l
1.4
1.6
0.56
17
50
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
99
592
1.69
5.72
1.3
1.3
u/l
96.8
44.2
1.63
86
514
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
57
288
1.99
5.64
1.1
1.1
—
2.4
—
0
5
(3011544) Albumin [Mass/volume] in Pleural fluid
15
37
4.07
5.62
1.1
1.1
g/l
15.4
15.9
0.11
15
30
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
28
104
2.71
5.59
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
166
1130
1.49
5.55
1.4
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
40
177
2.27
5.55
1.9
1.5
nmol/l
0.2
0.3
0.91
31
134
(3043409) Potassium [Moles/volume] in Arterial blood
155
1041
1.51
5.53
5.5
4.0
mmol/l
3.8
3.9
1.13
137
966
(3023103) Potassium [Moles/volume] in Serum or Plasma
3128
30198
1.27
5.52
39.4
19.4
mmol/l
4.0
4.0
0.38
3084
29370
(3003740) Influenza virus B Ag [Presence] in Specimen
55
278
1.99
5.45
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
805
6893
1.22
5.42
4.2
3.8
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
17
48
3.55
5.32
1.4
1.4
%
20.7
17.7
0.12
11
33
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
23
79
2.92
5.29
1.1
1.1
—
—
—
0
0
(40758358) Immune stain study
9
8
11.27
5.29
1.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
202
1443
1.42
5.27
10.1
5.1
%
1.6
1.6
0.35
184
1349
(3028468) Fragments [Presence] in Blood by Light microscopy
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
19
59
3.23
5.16
1.2
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
13
31
4.21
5.09
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
45
217
2.09
5.09
4.9
5.1
u/ml
38.8
44.1
0.07
11
59
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
23
81
2.85
5.08
1.1
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
37
165
2.26
5.07
1.9
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
762
8821
0.83
5.04
3.0
3.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
24
87
2.77
5.03
2.9
1.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
35
153
2.30
5.02
5.6
6.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
280
1.94
5.01
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
94
2.67
4.90
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
30
124
2.43
4.87
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
88
534
1.66
4.87
3.0
3.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
196
1422
1.40
4.72
10.9
5.2
%
0.9
0.9
0.19
179
1331
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
36
164
2.21
4.71
1.9
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
116
1726
0.66
4.63
1.7
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2633
25108
1.18
4.60
34.7
17.5
%
37.1
39.2
21.52
1683
16430
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
5
14.02
4.57
1.1
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
34
3.83
4.53
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3134
30389
1.24
4.49
24.1
11.1
u/l
26.9
26.2
0.79
3092
29131
(3018572) Chloride [Moles/volume] in Blood
117
781
1.51
4.37
15.5
6.9
mmol/l
105.0
105.2
0.09
101
695
(3039000) Anion gap in Blood
117
781
1.51
4.37
15.5
6.9
mmol/l
10.7
11.3
1.25
101
695
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
8
9
8.91
4.28
1.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
31
3.88
4.25
1.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
63
363
1.75
4.25
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
195
1441
1.37
4.24
2.5
2.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
65
379
1.73
4.21
1.2
1.2
u/ml
3.1
4.2
0.38
20
127
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
109
723
1.52
4.21
1.4
1.2
u/ml
44.8
38.0
0.14
14
35
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
103
676
1.54
4.18
1.4
1.2
u/ml
2.0
3.9
1.57
17
58
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
103
2.44
4.13
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
121
825
1.48
4.11
1.7
1.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
161
2.12
4.09
2.1
1.6
u/field
1.3
2.5
1.22
23
116
(4212803)
12
32
3.76
4.08
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
80
499
1.62
4.04
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
165
1197
1.40
4.02
2.0
2.2
ug/l
406.9
652.6
0.48
154
1131
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
7
7
10.02
4.01
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
7
10.02
4.01
1.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
7
10.02
4.01
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
103
686
1.52
3.93
1.4
1.2
u/ml
2.0
6.3
1.78
21
105
(3024869) Neuronal Ab [Presence] in Serum
16
54
2.97
3.84
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
498
1.60
3.84
1.3
1.2
u/ml
28.4
45.6
0.59
11
51
(40768441) Liver Pathology biopsy report
39
200
1.96
3.81
1.1
1.3
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
8
8.76
3.77
2.6
2.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
8
8.76
3.77
2.6
2.6
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
6
5
12.02
3.76
1.2
1.0
u/field
1.2
1.0
—
6
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
85
2.48
3.62
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
37
190
1.96
3.62
1.9
2.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
13
40
3.26
3.62
1.7
1.5
—
—
—
0
0
(3036603) Volume of Urine
38
197
1.94
3.62
1.6
1.6
ml
1819.9
1664.0
—
10
46
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
61
368
1.67
3.55
1.2
1.2
u/ml
3.1
5.7
1.57
25
160
(3000570) Elastase.pancreatic [Mass/mass] in Stool
128
910
1.42
3.54
1.5
1.4
ug/g
251.3
273.0
0.61
79
553
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1202
10972
1.14
3.48
4.7
4.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
113
2.22
3.41
3.4
2.4
—
—
—
0
0
(3019977) pH of Arterial blood
38
202
1.89
3.38
4.6
2.6
ph
7.4
7.4
0.04
13
74
(3008295) Osmolality of Serum or Plasma
55
329
1.68
3.32
1.3
1.3
mosm/kgh2o
272.9
276.4
0.68
48
244
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
43
3.03
3.25
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
222
2801
0.78
3.24
1.5
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
107
754
1.43
3.14
1.2
1.2
titre
109.2
95.0
0.22
13
58
(3041096) Erythrocytes [Presence] in Urine by Automated
841
7544
1.15
3.09
4.2
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
947
10413
0.88
3.00
4.0
4.0
mg/mmol
10.6
9.3
0.38
611
6666
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
40
3.01
2.97
1.0
1.2
—
—
—
0
0
(4015189)
21
94
2.24
2.96
1.3
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
34
183
1.87
2.95
2.1
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
18
76
2.38
2.89
1.5
2.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3118
30449
1.18
2.86
42.2
19.2
umol/l
84.2
82.4
1.59
3118
30438
(4268621)
44
260
1.70
2.83
2.1
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
766
6874
1.15
2.78
1.7
1.7
pmol/l
18283467.7
28081519.6
0.21
629
5623
(3045414) Leukocytes [Presence] in Urine
173
1347
1.30
2.75
2.0
2.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
78
2.31
2.74
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
85
2.24
2.70
1.3
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
76
1094
0.69
2.69
1.4
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
37
2.98
2.69
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
33
182
1.82
2.69
1.7
1.6
u/l
9.0
6.5
0.23
19
86
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
190
1.80
2.66
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
190
1.80
2.66
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
190
1.80
2.66
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2218
21228
1.12
2.65
4.0
3.9
pmol/l
15.0
15.0
0.56
2008
18997
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
147
1.91
2.65
1.0
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
130
978
1.34
2.64
1.4
1.2
u/ml
6.7
1.1
—
7
83
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
86
2.22
2.63
1.2
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
5
7
7.15
2.55
1.2
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
193
1.77
2.54
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
193
1.77
2.54
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
193
1.77
2.54
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
790
0.65
2.45
1.5
1.7
mg/l
3.1
3.9
0.37
42
572
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
45
2.67
2.45
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
55
359
1.54
2.43
1.4
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
362
3101
1.19
2.41
2.3
2.4
ug/l
7.6
7.3
0.07
304
2706
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
40
2.76
2.37
3.6
5.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
85
609
1.41
2.36
1.5
1.3
mmol/l
57.3
62.9
0.70
68
491
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
104
2.03
2.36
6.8
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
104
2.03
2.36
6.8
2.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
58
387
1.51
2.33
6.1
24.2
mmol/l
7.5
7.6
0.04
50
320
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
23
3.48
2.27
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
98
725
1.36
2.26
7.5
3.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
101
753
1.35
2.23
1.2
1.2
—
1160.0
—
0
20
(3027456) Digoxin [Moles/volume] in Serum or Plasma
103
771
1.35
2.21
3.1
3.1
nmol/l
1.0
0.8
0.82
74
582
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
20
102
1.97
2.10
1.2
2.1
e6/l
14363.3
21547.4
0.15
15
59
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
642
0.65
2.08
1.2
1.6
nmol/l
1.0
0.8
0.48
33
526
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
161
1.74
2.05
1.2
1.7
umol/l
4.9
13.3
1.23
16
105
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
20
3.50
2.05
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
181
1475
1.24
2.05
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
120
1532
0.78
2.02
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3008
29447
1.13
2.01
29.6
15.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
14
63
2.23
2.00
1.6
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
915
9875
0.90
1.99
3.4
3.3
mg/l
1165.1
283.6
3.05
598
6355
(3035320) C reactive protein [Mass/volume] in Body fluid
34
209
1.63
1.97
2.1
2.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
77
2.08
1.96
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
440
1.42
1.88
3.0
2.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
34
2.65
1.86
1.6
2.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
20
107
1.87
1.86
1.1
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
317
1.49
1.85
1.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
60
426
1.42
1.82
2.1
2.2
mg/l
29.8
22.3
0.51
18
101
(3004451) EKG impression Narrative
29
175
1.66
1.82
1.4
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
30
2.67
1.72
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
22
125
1.76
1.71
2.4
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
332
1.45
1.69
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
29
179
1.63
1.69
1.8
2.3
—
—
—
0
0
(3016750) Collection duration of Urine
31
196
1.59
1.65
2.2
2.1
min
517.2
487.7
1.00
15
145
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
77
1.95
1.59
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
77
1.95
1.59
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
77
1.95
1.59
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
77
1.95
1.59
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
26
2.70
1.58
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
67
889
0.75
1.57
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
339
2999
1.14
1.56
2.3
2.3
ug/g
203.7
157.3
0.98
284
2350
(3039443) Prostate specific Ag panel - Serum or Plasma
42
600
0.70
1.55
1.6
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
57
2.11
1.55
1.6
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
307
2702
1.15
1.53
4.4
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
954
10159
0.92
1.52
3.2
3.2
mmol/l
7.1
7.5
1.59
786
8435
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
20
116
1.73
1.48
2.8
1.9
ug/l
37.0
57.0
1.38
20
111
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
442
3993
1.12
1.47
13.0
7.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
98
1221
0.80
1.43
1.1
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
273
2398
1.15
1.41
2.5
2.2
nmol/l
13.0
12.6
0.33
248
2085
(44806420)
5
121
0.41
1.37
2.2
2.5
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
23
2.61
1.36
6.8
3.4
g/mol
14.3
30.4
—
6
23
(3029396) Erythrocyte agglutination [Presence] in Blood
6
23
2.61
1.36
1.0
2.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
23
2.61
1.36
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
162
0.49
1.35
1.3
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
299
1.41
1.33
1.0
1.0
u/ml
1.6
2.9
1.38
12
105
(4306422)
48
350
1.38
1.32
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
48
351
1.37
1.31
1.2
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
18
2.78
1.28
1.2
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
370
1.36
1.27
1.1
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
117
0.43
1.24
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
123
1.63
1.24
1.2
1.2
ratio
1.2
1.1
—
7
39
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
26
2.31
1.18
1.2
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
335
0.65
1.18
1.0
1.1
u/ml
14.3
2.0
—
6
145
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
31
214
1.45
1.18
1.2
1.2
—
115.0
—
0
6
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
133
1.58
1.17
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
226
1993
1.14
1.15
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
1249
0.83
1.12
1.3
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1006
10575
0.93
1.12
4.2
4.5
%
21.4
21.9
0.43
511
5460
(3017315) Amylase [Enzymatic activity/volume] in Urine
23
151
1.53
1.11
1.3
1.2
u/l
149.8
378.6
1.90
23
139
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
31
2.26
1.10
2.7
4.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
41
1.95
1.08
1.1
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
467
0.73
1.08
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
227
1.41
1.07
1.3
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
32
227
1.41
1.07
1.2
1.2
mmol/l
31.5
33.3
0.28
32
198
(3014891) Appearance of Pleural fluid
10
52
1.93
1.06
1.3
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
89
733
1.22
1.04
4.6
3.3
mmol/l
7.0
7.6
1.98
89
711
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
34
2.06
1.02
1.4
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
75
1.74
1.02
1.4
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
28
196
1.43
1.02
1.5
1.5
umol/l
15.6
14.1
0.49
28
183
(3034426) Prothrombin time (PT)
14
83
1.69
1.01
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
113
957
1.19
1.00
1.6
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
80
656
1.22
0.99
1.1
1.1
u/ml
4.5
7.2
—
10
56
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
285
0.66
0.99
1.0
1.1
u/ml
2.7
2.2
—
5
126
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
274
1.35
0.99
1.9
1.5
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
5
23
2.18
0.98
1.2
1.2
ml/s/173m2
1.7
0.9
—
5
17
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
7
36
1.95
0.97
6.3
4.9
ug/min
42.4
58.1
—
7
30
(3045716) Anion gap in Serum or Plasma
24
165
1.46
0.96
1.9
2.5
mmol/l
8.9
9.3
0.34
18
135
(3011648) Oxygen content in Venous blood
36
267
1.35
0.96
12.1
3.0
%
10.5
11.0
0.28
36
267
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
467
0.75
0.95
1.5
1.3
—
—
—
0
0
(4024509)
40
304
1.32
0.92
1.3
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
291
0.69
0.91
1.0
1.1
u/ml
12.4
4.9
—
7
145
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
94
1.60
0.90
1.4
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
29
210
1.38
0.90
1.4
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
36
271
1.33
0.89
2.3
2.0
u/field
2.1
2.2
0.01
16
98
(3001019) Free T4 and TSH panel - Serum or Plasma
66
805
0.82
0.88
1.6
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
95
1.58
0.87
1.5
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
189
1688
1.13
0.85
3.7
3.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
104
891
1.17
0.84
4.8
4.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
92
780
1.18
0.84
4.4
3.2
mmol/l
1.6
1.6
0.38
92
756
(3044941) Cell count panel - Synovial fluid
40
511
0.78
0.82
1.6
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
2.0
1.9
umol/l
20.4
17.1
—
6
32
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
121
1385
0.87
0.80
1.4
1.8
—
—
—
0
0
(4146454)
29
385
0.75
0.79
2.7
2.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
462
0.78
0.77
1.1
1.1
iu/ml
1.2
59.3
—
5
93
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
32.0
—
0
22
(40768800) Prostate Pathology biopsy report
74
876
0.84
0.76
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
394
4216
0.93
0.74
1.2
1.2
u/ml
11.9
14.0
0.24
127
1538
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
298
1.28
0.73
1.6
1.3
e6/l
13959.6
94754.8
1.55
28
208
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
76
1.58
0.71
1.1
1.1
%
73.7
85.3
—
7
43
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
15
101
1.49
0.70
1.2
2.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
41
1.71
0.70
7.6
14.6
mmol/l
8.8
5.6
—
7
41
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
68
574
1.19
0.69
1.3
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
135
1.41
0.69
1.2
1.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
77
1.56
0.68
1.1
1.3
%
78.0
83.9
—
7
45
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
16
110
1.46
0.68
3.0
2.8
umol/l
26.6
30.0
0.58
11
79
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
117
0.60
0.67
3.1
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
131
0.61
0.63
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
187
1705
1.10
0.63
2.4
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
223
0.72
0.62
1.2
2.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
19
138
1.38
0.62
1.4
1.3
mmol/l
6.0
6.2
0.21
19
132
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
30
235
1.28
0.61
1.3
1.1
u/ml
75.5
62.9
—
6
8
(3027944) Amphetamines [Presence] in Urine
38
466
0.81
0.60
1.2
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
42
344
1.22
0.59
1.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2781
28108
0.95
0.58
5.0
5.0
mmol/l
6.0
6.1
2.29
2516
25227
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
123
1.38
0.57
1.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
474
0.82
0.57
1.2
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
266
2848
0.93
0.55
1.6
1.8
%
1.5
1.6
0.28
218
2437
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
293
1.23
0.55
1.4
1.4
%
34.1
27.4
0.47
24
176
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2627
25963
1.04
0.54
4.8
4.7
mu/l
3.1
2.0
0.49
2388
23347
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
39
1.54
0.53
1.8
2.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
181
0.72
0.52
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
80
704
1.14
0.52
4.0
3.6
mg/l
25.8
30.2
0.76
55
445
(3014051) Protein [Presence] in Urine by Test strip
82
723
1.14
0.52
2.3
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
132
0.68
0.51
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
579
5552
1.05
0.51
1.2
1.2
u/ml
2.1
1.8
0.24
126
1402
(3009466) Valproate [Moles/volume] in Serum or Plasma
34
413
0.82
0.51
3.4
4.8
umol/l
304.4
350.6
1.04
27
360
(3016879) Cocaine [Presence] in Urine
37
445
0.83
0.50
1.2
2.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
247
0.77
0.50
1.0
1.0
ng/l
768.7
686.0
0.26
14
158
(4281824)
33
270
1.22
0.49
1.1
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
19
246
0.77
0.49
1.0
1.0
ng/l
44.0
44.8
0.06
13
159
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
19
246
0.77
0.49
1.0
1.0
ng/l
321.1
312.7
0.06
14
163
(3027008) Opiates [Presence] in Urine
40
475
0.84
0.48
1.2
1.9
—
—
—
0
0
(4010399)
199
2140
0.93
0.48
1.4
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
47
1.49
0.47
1.0
1.1
—
78.9
—
0
16
(3004775) Volume in Urine collected for unspecified duration
34
282
1.21
0.46
2.3
2.2
ml
826.3
630.5
0.98
18
181
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
16
120
1.33
0.46
1.0
1.1
iu/ml
123.1
238.0
2.05
16
120
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
118
0.68
0.45
1.9
1.8
nmol/l
2.0
8.9
—
8
101
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
38
449
0.84
0.44
1.2
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
216
2024
1.07
0.43
3.1
3.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
46
396
1.16
0.42
1.0
1.1
g/l
1.7
1.5
1.74
46
351
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
32
1.56
0.42
1.8
2.6
u/field
0.4
0.5
—
5
32
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
70
1.43
0.41
1.3
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
41
477
0.86
0.41
1.1
1.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
32
268
1.20
0.40
1.2
1.6
u/ml
39.2
22.9
—
5
56
(3035941) MCH [Entitic mass]
3159
31406
1.05
0.40
52.6
23.7
pg
30.5
30.4
2.08
3127
30853
(3024731) MCV [Entitic volume]
3159
31406
1.05
0.40
52.7
23.7
fl
92.1
91.5
10.63
3127
30854
(3001729) Color of Synovial fluid
5
34
1.47
0.40
1.6
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
1.0
—
0
11
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
149
0.74
0.40
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
88
1.36
0.40
1.1
1.1
u/ml
4.4
1.6
—
5
30
(3026361) Erythrocytes [#/volume] in Blood
3159
31408
1.05
0.40
52.9
23.8
e12/l
4.2
4.5
140.83
3092
30365
(3007461) Platelets [#/volume] in Blood
3158
31400
1.05
0.39
53.0
23.8
e9/l
216.0
242.9
74.33
3097
30471
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.3
—
365.1
—
0
19
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
196
1.23
0.39
2.1
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
36
1.39
0.38
1.0
1.2
umol/24h
2.1
1.9
—
5
36
(3000963) Hemoglobin [Mass/volume] in Blood
3159
31415
1.05
0.38
53.1
24.0
g/l
124.7
134.8
187.59
3126
30863
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
67
1.34
0.38
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
67
1.34
0.38
1.1
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3159
31416
1.04
0.37
52.9
23.8
e9/l
6.7
6.8
0.84
3094
30374
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
735
7559
0.97
0.37
2.8
3.2
ug/l
0.8
0.8
0.35
509
5306
(3027923) C peptide [Moles/volume] in Serum or Plasma
12
158
0.76
0.37
1.5
1.3
nmol/l
1.3
1.1
—
6
122
(40768793) Breast Pathology biopsy report
62
556
1.12
0.34
1.3
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
73
1.37
0.34
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
157
1472
1.07
0.34
1.2
1.2
iu/ml
137.5
138.9
0.01
43
521
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
133
0.75
0.33
1.7
1.3
—
1.3
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
13
166
0.78
0.33
1.4
1.5
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
46
1.30
0.33
1.0
1.1
—
75.9
—
0
14
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
89
0.67
0.33
1.3
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
137
1.24
0.32
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
174
1837
0.94
0.29
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
185
0.81
0.29
1.1
1.3
u/ml
0.4
1.2
—
6
93
(3014271) Vancomycin [Susceptibility]
23
194
1.19
0.29
2.4
2.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
75
689
1.09
0.28
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
76
1.32
0.28
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
42
374
1.12
0.28
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
379
3917
0.96
0.27
4.3
4.8
%
31.3
32.8
1.76
262
2552
(3024263) Appearance of Synovial fluid
15
183
0.82
0.27
1.5
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
66
1.21
0.26
7.3
7.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
19
225
0.84
0.26
1.3
2.0
mmol/l
7.9
6.8
0.76
14
149
(3006462) Nitrate [Presence] in Urine
18
150
1.20
0.26
2.8
4.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1300
13183
0.98
0.25
4.7
5.3
ug/l
2.9
3.8
1.02
1142
11774
(4211845)
19
160
1.19
0.25
2.7
3.9
—
—
—
0
0
(4094501)
77
830
0.93
0.25
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
45
406
1.11
0.25
1.6
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
35
311
1.13
0.25
3.6
3.2
mg/l
23.5
29.8
0.25
27
249
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
77
1.17
0.24
1.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
78
1.28
0.24
4.7
5.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
370
0.89
0.23
1.2
2.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
115
1.22
0.23
1.2
2.4
umol/l
108.1
111.9
—
9
69
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
40
1.25
0.22
2.0
2.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.2
—
7.8
—
0
11
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
11
0.00
0.21
0.0
11.8
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
2.0
—
0
10
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
182
1.15
0.21
1.4
1.6
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.3
nmol/l
11.0
5.3
—
5
34
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
13
0.00
0.21
0.0
1.0
—
89.3
—
0
8
(3030313) Adrenal Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
82
872
0.94
0.20
1.5
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
303
0.89
0.20
1.3
1.3
mmol/l
7.8
7.5
0.14
21
223
(4034850)
88
933
0.94
0.20
12.7
10.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
136
1.18
0.20
1.6
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
80
850
0.94
0.19
2.6
2.3
ug/min
191.7
100.6
0.53
51
516
(3000285) Sodium [Moles/volume] in Blood
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
166
1.15
0.18
2.5
2.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
82
1.22
0.17
2.8
3.1
—
—
—
0
0
(4198724)
5
69
0.72
0.17
1.0
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
68
1.18
0.16
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
281
2881
0.97
0.15
1.4
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
76
0.79
0.15
1.0
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
80
0.75
0.15
2.8
2.2
nmol/l
130.2
134.8
—
6
69
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
83
1.21
0.15
2.3
1.9
ug/l
1.3
1.3
—
10
75
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
64
605
1.06
0.15
2.0
1.8
iu/l
11.3
4.4
1.28
19
190
(3000492) Spirometry study
261
2546
1.03
0.14
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
314
1.08
0.14
1.1
2.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
76
724
1.05
0.14
1.5
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
37
398
0.93
0.14
1.3
1.3
nmol/l
0.7
0.7
0.05
37
376
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
10
84
1.19
0.14
1.3
2.6
%
272.4
179.1
—
10
76
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
28
304
0.92
0.13
1.3
1.3
nmol/l
1.3
1.5
0.53
23
271
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
364
0.93
0.11
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
168
0.89
0.11
10.9
13.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
105
1.14
0.11
1.2
2.1
ug/l
266.4
96.8
0.28
12
93
(3032773) Endomysium IgG Ab [Titer] in Serum
21
192
1.09
0.10
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
18
198
0.91
0.10
1.0
1.2
mmol/l
14.1
12.3
—
6
64
(3003338) MCHC [Mass/volume]
2312
23203
0.99
0.10
46.1
21.2
g/l
331.2
332.2
5.46
2292
22996
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
642
6358
1.01
0.09
4.8
4.3
kg/l
1.0
1.0
0.40
105
977
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
196
0.92
0.09
1.0
1.1
u/ml
2.3
3.9
—
5
82
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
56
1.07
0.08
2.2
1.5
—
—
—
0
0
(4133840)
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
154
0.91
0.08
1.4
1.2
nmol/l
115.1
139.9
2.60
14
154
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
561
0.96
0.07
1.2
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
174
0.92
0.07
2.1
1.5
g/l
0.9
1.0
0.34
16
174
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
34
357
0.95
0.07
1.2
1.4
pmol/l
254.9
282.6
0.35
27
275
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
9
86
1.05
0.07
2.2
1.5
pmol/l
14.8
15.0
—
9
70
(3022689) Creatine [Moles/volume] in Urine
9
87
1.03
0.07
2.1
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
393
1.04
0.07
1.5
1.5
%
62.3
62.1
0.01
26
243
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
141
0.92
0.05
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
141
0.92
0.05
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
140
0.93
0.04
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
140
0.93
0.04
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
11
101
1.09
0.04
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
119
0.92
0.04
1.5
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
92
1.09
0.03
6.4
7.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
117
0.94
0.01
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
443
4444
1.00
0.01
1.2
1.3
iu/ml
53.0
37.7
0.81
142
1378
(3005033) Fetal Nuchal fold Thickness US
11
116
0.95
0.00
1.3
1.4
—
—
—
0
0
(44813793)
15
156
0.96
0.00
1.1
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
39
384
1.02
0.00
1.3
1.4
mu/l
48.8
67.6
0.45
33
340
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
108
1.02
0.00
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
152
0.99
0.00
1.5
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
22
218
1.01
0.00
1.3
1.4
promille
1.4
1.2
0.19
17
168
(3023511) Choriogonadotropin [Units/volume] in Urine
14
135
1.04
0.00
1.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
58
575
1.01
0.00
1.5
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
191
0.99
0.00
1.7
1.4
pmol/l
82.6
192.8
—
10
69
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
351
1.00
0.00
1.3
1.3
nmol/l
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
76
764
0.99
0.00
1.9
1.6
e6/l
17078.7
14099.5
0.18
61
551
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.4
—
0
6
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
81
0.99
0.00
7.3
8.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
30.6
—
0
8
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
36.5
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
85
0.94
0.00
1.9
1.4
ug/l
11.9
9.1
—
8
85
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
6
68
0.88
0.00
1.3
1.3
mu/l
78.7
66.7
—
6
52
(4038314)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1740.0
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
-0.00
0.0
6.1
—
57.9
—
0
7
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
-0.00
0.0
5.3
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.1
—
433.7
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).